Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients
- 23 August 2009
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 65 (6) , 1057-1066
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastomaCancer Chemotherapy and Pharmacology, 2008
- Improving recruitment to clinical trials for cancer in childhoodThe Lancet Oncology, 2008
- Adaptive dosing and platinum–DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumoursBritish Journal of Cancer, 2007
- Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemiaCancer Chemotherapy and Pharmacology, 2006
- Etoposide pharmacokinetics in children treated for acute myeloid leukemiaAnti-Cancer Drugs, 2006
- Guidelines on Paediatric Dosing on the Basis of Developmental Physiology and Pharmacokinetic ConsiderationsClinical Pharmacokinetics, 2006
- Pharmacokinetics of etoposide with intravenous drug administration in children and adolescentsPediatrics International, 2003
- Dosing strategies for anticancer drugs: the good, the bad and body-surface areaEuropean Journal of Cancer, 2002
- A Phase I/II Dose Escalation Study of Carboplatin in the Treatment of Newly Diagnosed Patients With Advanced Ovarian Cancer Receiving PaclitaxelAmerican Journal of Clinical Oncology, 1999
- Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study.Journal of Clinical Oncology, 1992